ClinicalTrials.Veeva

Menu

Comparison of 4 Tactical Tourniquets Used in War Medicine

D

Direction Centrale du Service de Santé des Armées

Status

Completed

Conditions

Hemorrhage

Treatments

Device: Tactical tourniquet set up
Other: Questionnaire
Diagnostic Test: Medical ultrasound

Study type

Interventional

Funder types

Other

Identifiers

NCT04870814
2021-A00049-32 (Other Identifier)
2020PPRC05

Details and patient eligibility

About

Bleeding remains the leading cause of death in combat, and the literature suggests that tourniquetable hemorrhage is the second leading cause of preventable death, behind non- tourniquetable hemorrhage.

Currently, most Western armed forces recommend the use of the tactical tourniquet in combat for the management of tourniquetable hemorrhage.

The SOFTT® tourniquet (Tactical Medical Solutions, Anderson) is the tactical tourniquet currently in use by the French armed forces. As the contract will soon come to an end, the question of its renewal arises.

The purpose of this study is to compare 4 commercially available tactical tourniquets in healthy volunteers.

The hypothesis of the research is that one of the 4 tourniquets compared is faster to set up than the others.

Enrollment

46 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age ≥ 18 years;
  • Student of the Military Health School of Lyon Bron (Ecoles Militaires de Santé de Lyon Bron; EMSLB);
  • Periodic medical examination up to date with the mention "fitness for duty";
  • Holder of the "Combat Rescue Level 1" training.

Exclusion criteria

  • Vascular pathology;
  • Current progressive pathology of any kind;
  • History of thrombo-embolic disease;
  • Presence of cardiovascular risk factors (diabetes, hypertension, dyslipidemia, smoking > 1 cigarette/day, BMI > 25);
  • Iliofemoral and axillary vascular abnormalities detected by systematic Doppler ultrasound;
  • Presence of symptoms suggestive of COVID-19;
  • Positive COVID-19 antigen test;
  • In contact with a person diagnosed positive for COVID-19 within 15 days prior to inclusion;
  • Pregnant or breastfeeding woman.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

46 participants in 4 patient groups

SOFTT® Gen 4 tactical tourniquet
Active Comparator group
Description:
The SOFTT® Gen 4 (Tactical Medical Solutions, Anderson) tactical tourniquet will be assessed.
Treatment:
Other: Questionnaire
Diagnostic Test: Medical ultrasound
Device: Tactical tourniquet set up
CAT® Gen 7 tactical tourniquet
Active Comparator group
Description:
The CAT® Gen 7 (C-A-T® Resources, Rock Hill) tactical tourniquet will be assessed.
Treatment:
Other: Questionnaire
Diagnostic Test: Medical ultrasound
Device: Tactical tourniquet set up
SAM XT® tactical tourniquet
Active Comparator group
Description:
The SAM XT® (SAM Medical Products®, Wilsonville) tactical tourniquet will be assessed.
Treatment:
Other: Questionnaire
Diagnostic Test: Medical ultrasound
Device: Tactical tourniquet set up
RMT® 1.5 tactical tourniquet
Active Comparator group
Description:
The RMT® 1.5 (m2®, Winooski) tactical tourniquet will be assessed.
Treatment:
Other: Questionnaire
Diagnostic Test: Medical ultrasound
Device: Tactical tourniquet set up

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems